Clinical trial
Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma
The purpose of this study is to understand if small proteins found on the surface of myeloma cells (called CXCR4, CD47, and beta 2 adrenergic receptors) can predict how patients will respond to chemotherapy-treatment and if a small molecule inside the myeloma cells (called Pim kinase) can be used as a treatment target for myeloma.
Category | Value |
---|---|
Study start date | 2011-07-13 |